TUDOR INVESTMENT CORP ET AL - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$635
-16.2%
19,719
-52.0%
0.01%
-33.3%
Q4 2022$758
-99.9%
41,076
-44.6%
0.02%
-44.4%
Q2 2022$1,024,000
-41.4%
74,119
-17.3%
0.03%
-34.1%
Q1 2022$1,747,000
-8.8%
89,572
+38.6%
0.04%
+13.9%
Q2 2021$1,915,000
+417.6%
64,616
+137.6%
0.04%
+350.0%
Q2 2016$370,000
-1.6%
27,200
+147.3%
0.01%
-27.3%
Q4 2015$376,00011,0000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders